Cargando…

Lab on a Chip Device for Diagnostic Evaluation and Management in Chronic Renal Disease: A Change Promoting Approach in the Patients’ Follow Up

Lab-on-a-chip (LOC) systems are miniaturized devices aimed to perform one or several analyses, normally carried out in a laboratory setting, on a single chip. LOC systems have a wide application range, including diagnosis and clinical biochemistry. In a clinical setting, LOC systems can be associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Borriello, Margherita, Tarabella, Giuseppe, D’Angelo, Pasquale, Liboà, Aris, Barra, Mario, Vurro, Davide, Lombari, Patrizia, Coppola, Annapaola, Mazzella, Elvira, Perna, Alessandra F., Ingrosso, Diego
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046018/
https://www.ncbi.nlm.nih.gov/pubmed/36979584
http://dx.doi.org/10.3390/bios13030373
_version_ 1785013560825348096
author Borriello, Margherita
Tarabella, Giuseppe
D’Angelo, Pasquale
Liboà, Aris
Barra, Mario
Vurro, Davide
Lombari, Patrizia
Coppola, Annapaola
Mazzella, Elvira
Perna, Alessandra F.
Ingrosso, Diego
author_facet Borriello, Margherita
Tarabella, Giuseppe
D’Angelo, Pasquale
Liboà, Aris
Barra, Mario
Vurro, Davide
Lombari, Patrizia
Coppola, Annapaola
Mazzella, Elvira
Perna, Alessandra F.
Ingrosso, Diego
author_sort Borriello, Margherita
collection PubMed
description Lab-on-a-chip (LOC) systems are miniaturized devices aimed to perform one or several analyses, normally carried out in a laboratory setting, on a single chip. LOC systems have a wide application range, including diagnosis and clinical biochemistry. In a clinical setting, LOC systems can be associated with the Point-of-Care Testing (POCT) definition. POCT circumvents several steps in central laboratory testing, including specimen transportation and processing, resulting in a faster turnaround time. Provider access to rapid test results allows for prompt medical decision making, which can lead to improved patient outcomes, operational efficiencies, patient satisfaction, and even cost savings. These features are particularly attractive for healthcare settings dealing with complicated patients, such as those affected by chronic kidney disease (CKD). CKD is a pathological condition characterized by progressive and irreversible structural or functional kidney impairment lasting for more than three months. The disease displays an unavoidable tendency to progress to End Stage Renal Disease (ESRD), thus requiring renal replacement therapy, usually dialysis, and transplant. Cardiovascular disease (CVD) is the major cause of death in CKD, with a cardiovascular risk ten times higher in these patients than the rate observed in healthy subjects. The gradual decline of the kidney leads to the accumulation of uremic solutes, with negative effect on organs, especially on the cardiovascular system. The possibility to monitor CKD patients by using non-invasive and low-cost approaches could give advantages both to the patient outcome and sanitary costs. Despite their numerous advantages, POCT application in CKD management is not very common, even if a number of devices aimed at monitoring the CKD have been demonstrated worldwide at the lab scale by basic studies (low Technology Readiness Level, TRL). The reasons are related to both technological and clinical aspects. In this review, the main technologies for the design of LOCs are reported, as well as the available POCT devices for CKD monitoring, with a special focus on the most recent reliable applications in this field. Moreover, the current challenges in design and applications of LOCs in the clinical setting are briefly discussed.
format Online
Article
Text
id pubmed-10046018
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100460182023-03-29 Lab on a Chip Device for Diagnostic Evaluation and Management in Chronic Renal Disease: A Change Promoting Approach in the Patients’ Follow Up Borriello, Margherita Tarabella, Giuseppe D’Angelo, Pasquale Liboà, Aris Barra, Mario Vurro, Davide Lombari, Patrizia Coppola, Annapaola Mazzella, Elvira Perna, Alessandra F. Ingrosso, Diego Biosensors (Basel) Review Lab-on-a-chip (LOC) systems are miniaturized devices aimed to perform one or several analyses, normally carried out in a laboratory setting, on a single chip. LOC systems have a wide application range, including diagnosis and clinical biochemistry. In a clinical setting, LOC systems can be associated with the Point-of-Care Testing (POCT) definition. POCT circumvents several steps in central laboratory testing, including specimen transportation and processing, resulting in a faster turnaround time. Provider access to rapid test results allows for prompt medical decision making, which can lead to improved patient outcomes, operational efficiencies, patient satisfaction, and even cost savings. These features are particularly attractive for healthcare settings dealing with complicated patients, such as those affected by chronic kidney disease (CKD). CKD is a pathological condition characterized by progressive and irreversible structural or functional kidney impairment lasting for more than three months. The disease displays an unavoidable tendency to progress to End Stage Renal Disease (ESRD), thus requiring renal replacement therapy, usually dialysis, and transplant. Cardiovascular disease (CVD) is the major cause of death in CKD, with a cardiovascular risk ten times higher in these patients than the rate observed in healthy subjects. The gradual decline of the kidney leads to the accumulation of uremic solutes, with negative effect on organs, especially on the cardiovascular system. The possibility to monitor CKD patients by using non-invasive and low-cost approaches could give advantages both to the patient outcome and sanitary costs. Despite their numerous advantages, POCT application in CKD management is not very common, even if a number of devices aimed at monitoring the CKD have been demonstrated worldwide at the lab scale by basic studies (low Technology Readiness Level, TRL). The reasons are related to both technological and clinical aspects. In this review, the main technologies for the design of LOCs are reported, as well as the available POCT devices for CKD monitoring, with a special focus on the most recent reliable applications in this field. Moreover, the current challenges in design and applications of LOCs in the clinical setting are briefly discussed. MDPI 2023-03-12 /pmc/articles/PMC10046018/ /pubmed/36979584 http://dx.doi.org/10.3390/bios13030373 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Borriello, Margherita
Tarabella, Giuseppe
D’Angelo, Pasquale
Liboà, Aris
Barra, Mario
Vurro, Davide
Lombari, Patrizia
Coppola, Annapaola
Mazzella, Elvira
Perna, Alessandra F.
Ingrosso, Diego
Lab on a Chip Device for Diagnostic Evaluation and Management in Chronic Renal Disease: A Change Promoting Approach in the Patients’ Follow Up
title Lab on a Chip Device for Diagnostic Evaluation and Management in Chronic Renal Disease: A Change Promoting Approach in the Patients’ Follow Up
title_full Lab on a Chip Device for Diagnostic Evaluation and Management in Chronic Renal Disease: A Change Promoting Approach in the Patients’ Follow Up
title_fullStr Lab on a Chip Device for Diagnostic Evaluation and Management in Chronic Renal Disease: A Change Promoting Approach in the Patients’ Follow Up
title_full_unstemmed Lab on a Chip Device for Diagnostic Evaluation and Management in Chronic Renal Disease: A Change Promoting Approach in the Patients’ Follow Up
title_short Lab on a Chip Device for Diagnostic Evaluation and Management in Chronic Renal Disease: A Change Promoting Approach in the Patients’ Follow Up
title_sort lab on a chip device for diagnostic evaluation and management in chronic renal disease: a change promoting approach in the patients’ follow up
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046018/
https://www.ncbi.nlm.nih.gov/pubmed/36979584
http://dx.doi.org/10.3390/bios13030373
work_keys_str_mv AT borriellomargherita labonachipdevicefordiagnosticevaluationandmanagementinchronicrenaldiseaseachangepromotingapproachinthepatientsfollowup
AT tarabellagiuseppe labonachipdevicefordiagnosticevaluationandmanagementinchronicrenaldiseaseachangepromotingapproachinthepatientsfollowup
AT dangelopasquale labonachipdevicefordiagnosticevaluationandmanagementinchronicrenaldiseaseachangepromotingapproachinthepatientsfollowup
AT liboaaris labonachipdevicefordiagnosticevaluationandmanagementinchronicrenaldiseaseachangepromotingapproachinthepatientsfollowup
AT barramario labonachipdevicefordiagnosticevaluationandmanagementinchronicrenaldiseaseachangepromotingapproachinthepatientsfollowup
AT vurrodavide labonachipdevicefordiagnosticevaluationandmanagementinchronicrenaldiseaseachangepromotingapproachinthepatientsfollowup
AT lombaripatrizia labonachipdevicefordiagnosticevaluationandmanagementinchronicrenaldiseaseachangepromotingapproachinthepatientsfollowup
AT coppolaannapaola labonachipdevicefordiagnosticevaluationandmanagementinchronicrenaldiseaseachangepromotingapproachinthepatientsfollowup
AT mazzellaelvira labonachipdevicefordiagnosticevaluationandmanagementinchronicrenaldiseaseachangepromotingapproachinthepatientsfollowup
AT pernaalessandraf labonachipdevicefordiagnosticevaluationandmanagementinchronicrenaldiseaseachangepromotingapproachinthepatientsfollowup
AT ingrossodiego labonachipdevicefordiagnosticevaluationandmanagementinchronicrenaldiseaseachangepromotingapproachinthepatientsfollowup